Valentia Biopharma S.L.

Valentia Biopharma is a biotechnology company, established in August 2006 as an spin-off from the University of Valencia.
Valentia Biopharma is the result of over 12 years of academic research at the Translational Genomics Group at University of Valencia. This innovative company is committed to scientific research and applying its acquired knowledge to the world of business.
We work on the research and development of new types of therapy that provide effective solutions for human pathologies which cannot be effectively treated yet.
To attain this objective, the company has developed a biotechnological platform that studies new pharmaceutical drugs and organises research programmes initially focused on genetic pathologies such as Myotonic Dystrophy.
Valentia Biopharma's work centers on the earliest stages of research and development of a drug, namely, in finding the main potential therapeutical agents that can be used to treat human genetic diseases that are under our study.

Status: 

Out of Business

Industries: 

Employee Count Range: 

11-50

Company type: 

Privately Held

Founded year: 

2006

Share this page